Medicare patients represent between 70 and 75 percent of all procedures to place pacemakers, defibrillators and other cardiac rhythm devices. Use of MRI-compatible pacemakers in those procedures grew from 12.3 percent in 2016 to 73.6 percent in 2018.
However, an uptick in the cost of CRM devices that are MRI-compliant has increased hospitals’ total spend on the devices by 8 percent, as Medicare has not increased what it reimburses for the more expensive devices. This translates to more than $400 million in cost increases for U.S. hospitals each year, according to the report.
“While there is clear clinical benefit to MRI-compatible devices, utilization data suggests that appropriate patient selection will be an important factor in effectively managing overall CRM device spend,” according to the report.
More articles on healthcare finance:
6-hospital Verity Health files for bankruptcy
NewYork-Presbyterian’s net income tumbles 47%
AMA releases 335 coding changes for 2019
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
